LD (@ldbioinv) header
LD (@ldbioinv) profile picture

Biotech Investor

Boston, MA
Joined September 2025
Photo by LD (@ldbioinv)Photo by LD (@ldbioinv)Photo by LD (@ldbioinv)Photo by LD (@ldbioinv)Photo by LD (@ldbioinv)Photo by LD (@ldbioinv)
LD retweeted
Obe is a decent drug. Ico is a good drug. Emvi is not great. Rezpeg is bad. Tibu is TBD but I’m skeptical. Everyone needs to chill.
6
2
1
30
7,198
LD retweeted
Replying to @A_May_MD
$ZURA Disagree. This is yet another data point suggestive of high pbo response in more contemporary trials.
1
1
9
1,932
Is $VKTX going to disclose that the chief commercial officer left the company?
6
2
15
7,664
By the way, Vabysmo had only 45% of patients getting to 16w interval in the first year vs. 54% patients with 24w interval for Zenkuda. A very clear and significant difference in my view. And this is with much less strict retreatment criteria than $KOD.
$KOD With 54% of patients every 24m treatment and clean safety, this drug, in my view, is the best option for wAMD as of now. Take in account that they also used a far more stringent re-treatment criteria than anyone of the other agents currently on the market. Clean safety with almost no inflammation and no cataract (which was a concern before this read out). The whole IL-6 wAMD and MESi (Macular edema) story on top all of that. Financing will not be an issue at all with those results and Bakers as a lead. With no really interesting assets out there in ophthalmology and the hunger for acquisitions in this space, how is this not a clean take out in few months?
There's a new version of this post
1
1
1,104
I don’t get how folks like $TENX and are overlooking $CRDL. Upside is analogous though I think later is closer to a true 50:50 .
3
3
24
6,211
My favorite shorts are the ones where longs operate in their own reality, with an event forcing their view to converge to reality. Everyone is acting like this one off event is a referendum on rare disease at the FDA… have you not been paying attention for the last year?
Other than potential conspiracy theories, can anyone explain to me how for past 6 months @DrMakaryFDA is all over the media touting flexibility in trials, using RWE in trials, speeding up access to trials that demonstrate efficacy then tell @uniQure_NV $QURE they need to design a placebo-controlled trial with one of the largest databases of disease progression available for any rare disease. The knowledge being gained from this database continues growing daily. It sure sounds to me that there is some underlying sinister reason for this kind of behavior. I hate believing in conspiracies, especially in this situation, but sometimes evidence sure makes them believable. This outcome makes absolutely no sense. Good luck in recruiting patients into a trial with a RCT placebo arm for one of the cruelest deadly diseases out there. Enrolling in this kind of trial would prevent patients who may have gotten the placebo from entering any other trial. Dr Makary understands this. How can he support this kind of outcome?
5
1
29
11,218
$IMMX It is possible we are seeing emergence of a functional cure for this nasty sever disease. Sure, first it will go for the r/r patients, but whoever will buy them out can move to the first. Patients can be cure directly after the diagnosis, without the need of taking chronic drugs for years and preventing any continuation of slow deterioration of the organs. Also, just secured a nice pipe. Supper cheap here. ~$150MM EV
3
4
24
6,967
NS Pharma’s confirmatory Viltepso DMD study failed last year, but Tidmarsh using plural tense here - $SRPT confirmatory readouts expected imminently - also what does this mean for $RNA, $DYN DMD AA paths?
FDA's top drug regulator, George Tidmarsh, with a potentially market-moving LinkedIn post for DMD developers like Sarepta... Odd that this wasn't sent through official channels.
1
1
1,423
Replying to @adamfeuerstein
$REPL more likely up today on Jefferies note suggesting lack of AA path resolution at Type A mtg last week bc time didn’t permit, but co is continuing dialogue w/ FDA and will have an update once mtg mins are received (~10/16)
1
1
7
736